Welcome to the Exhibitor Hall for the 2026 Annual Conference
AbbVie discovers and delivers innovative medicines and solutions that enhance people’s lives.
Axsome is developing therapies for CNS conditions with limited treatment options. By creating treatments with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are committed to developing therapeutic approaches that meaningfully improve the lives of patients and provide additional options for physicians.
Braeburn is dedicated to transforming the management of OUD to help people begin and sustain their recovery. At Braeburn, we challenge the status quo and champion transformation of the management of OUD. We partner with the community to create a world where every person with OUD gets the best possible care and opportunity to reach their full potential. Visit Braeburnrx.com or brixadi.com.
At Bristol Myers Squibb, we are focused on accelerating the development of new medicines that address symptoms of neuropsychiatric conditions like schizophrenia. We work to deliver medications with unique mechanisms of action to provide differentiated options for patients and elevate the standard of care. Find out more.
The Janssen Pharmaceutical Companies of Johnson & Johnson is now J&J Innovative Medicine. We’ve been part of Johnson & Johnson and now our identity better conveys that. Our new brand truly reflects the best of who we are and what we do to lead where medicine is going. Patients Inform and inspire our science-based innovations, which continue to change and save lives.
Mindful Therapy Group supports more than 2,000 therapists and psychiatric nurse practitioners across five states with comprehensive administrative and business services. By managing insurance credentialing, billing, compliance, and more, Mindful enables providers to focus on delivering quality patient care and growing their practices. Learn more at mindfultherapygroup.com or contact moc.secivrestroppuslufdnim@gnitekram.
We are motivated by people living with diseases and conditions that are without viable treatment options. We identify the greatest needs and work relentlessly to bring hope to those who need it most. Visit neurocrine.com.
Otsuka America Pharmaceutical, Inc. (OAPI) is an innovative healthcare company that commercializes Otsuka-discovered and in-licensed products in the U.S., with a focus on neuroscience, nephrology, and medical devices. For more information, visit https://www.otsuka-us.com/home.
Teva Pharmaceutical Industries Ltd. has been developing and producing medicines to improve people’s lives for more than a century. We offer generic, biosimilars and innovative medicines with a portfolio consisting of over 3,600 products in nearly every therapeutic area. Learn more at www.tevapharm.com.
©2023 Teva Neuroscience, Inc. NPS-40586 May 2023
Tris Pharma
At L&I, we know healthcare providers are essential to ensuring workers recover and return to work. As Washington’s workers compensation payer, we strive to be good partners by offering providers dedicated support and resources.
For more information, contact us at vog.aw.inL@kcabdeefredivorP.











